|
Accupril |
| 42 |
Accupril 5mg |
79.99 |
| 42 |
Accupril 10mg |
139.99 |
| 42 |
Accupril 20mg |
219.99 |
| 84 |
Accupril 5mg |
139.99 |
| 84 |
Accupril 10mg |
259.99 |
| 84 |
Accupril 20mg |
249.99 |
| 126 |
Accupril 5mg |
189.99 |
| 126 |
Accupril 10mg |
319.99 |
| 126 |
Accupril 20mg |
349.99 |
|
 |
Accupril Hypertension Medication
Drug Information
Hypertension Medication Accupril Side Effects:
The most
frequent clinical adverse reactions in controlled trials with
Accupril were (in descending order of frequency) headache,
dizziness, rhinitis, coughing, upper respiratory tract
infection, fatigue, dyspepsia, nausea and vomiting, myalgia,
abdominal pain, diarrhoea, insomnia, paresthesia, nervousness,
asthenia, hypotension and leucopenia.
Less frequent adverse events that have been reported include:
palpitations, vasodilatation, dry mouth or throat, pancreatitis,
vertigo, nervousness, depression, somnolence, pruritus, rash,
exfoliative dermatitis, pemphigus, increased perspiration,
alopecia, urinary tract infection, impotence, edema, arthralgia,
hemolytic anaemia, and angioedema.
Creatinine and Blood Urea Nitrogen: Increases (>1,25 times the
upper limit of normal) in serum creatinine and blood urea
nitrogen may occur especially with concomitant diuretic therapy.
Precautions on using Accupril Hypertension Medication
Angioedema:
Angioedema, including laryngeal edema, may occur, especially
following the first dose of ACCUPRIL. Patients should be so
advised and told to report immediately any signs or symptoms
suggesting angioedema (swelling of face, eyes, lips, tongue,
difficulty in breathing) and to discontinue medication until
they have consulted with their physician.
If laryngeal stridor or angioedema of the face, tongue, or
glottis occur, treatment with ACCUPRIL should be discontinued
immediately, the patient treated appropriately in accordance
with accepted medical care, and carefully observed until the
swelling disappears. Angioedema associated with laryngeal
involvement may be fatal. Where there is involvement of the
tongue, glottis, or larynx likely to cause airway obstruction,
appropriate therapy e.g., subcutaneous adrenalin solution 1:1000
(0,3 to 0,5 mL) should be promptly administered.
|
